Multiomic evidence of coordinated complex rearrangements, enhancer hijacking, and epigenomic signatures in the first whole-chromosome-phased myeloma genomes - Brian Walker, PhD | Abstract
Sensitive detection of novel structural variants and 3D chromosome conformation reveals likely novel drivers including enhancer hijacking in AML - Thomas Koehnke, MD | Abstract
Chromothripsis drives high-risk multiple myeloma by copy number abnormalities and rewiring the epigenome to activate oncogenic programs - Enze Liu, Ph.D. | Abstract
The 67th ASH Annual Meeting and Exposition will take place December 6-9, 2025, in Orlando, Florida, and online. Mark your calendars now to attend the world’s most comprehensive hematology event of the year!